Industry researchers estimate that while about 12% of United States citizens have used a GLP-1 medication for weight loss, 54% of adults who have taken GLP-1s say it was difficult to afford, and 53% say it was still too expensive even if they received insurance coverage for the medication
Petruzzelli G, Pedron F, Rosellini I (2020) Bioavailability and bioaccessibility in soil: a short review and a case study
Adipose-selective fat metabolism
Eligibility is based on body mass index, medical history, and overall health assessment
While this validated the bitter detection system (it was detecting an actual toxin), it obviously couldn't be commercialized
Be patient but persistent: Weight management takes time and consistent effort